美股A股
StockGist
Back
8-K2026-03-12· grok-4-1-fast-non-reasoning

XLO · Xilio Therapeutics, Inc.

0001193125-26-103150

SEC filing

Summary

Xilio Therapeutics, Inc. filed a Certificate of Amendment to its Restated Certificate of Incorporation on March 12, 2026, constituting an amendment to its articles of incorporation and a material modification to the rights of security holders. Exhibit 3.1 contains the Certificate of Amendment.

Key takeaways